CTAC NV (CTAC.AS) Fundamental Analysis & Valuation

AMS:CTAC • NL0000345577

Current stock price

2.92 EUR
+0.06 (+2.1%)
Last:

This CTAC.AS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. CTAC.AS Profitability Analysis

1.1 Basic Checks

  • In the past year CTAC was profitable.
  • In the past year CTAC had a positive cash flow from operations.
  • Each year in the past 5 years CTAC has been profitable.
  • In the past 5 years CTAC always reported a positive cash flow from operatings.
CTAC.AS Yearly Net Income VS EBIT VS OCF VS FCFCTAC.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M 10M 15M

1.2 Ratios

  • CTAC has a better Return On Assets (7.74%) than 84.29% of its industry peers.
  • The Return On Equity of CTAC (16.41%) is better than 72.86% of its industry peers.
  • CTAC has a Return On Invested Capital of 9.71%. This is in the better half of the industry: CTAC outperforms 67.14% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CTAC is in line with the industry average of 11.52%.
Industry RankSector Rank
ROA 7.74%
ROE 16.41%
ROIC 9.71%
ROA(3y)3.98%
ROA(5y)4.84%
ROE(3y)8.98%
ROE(5y)11.99%
ROIC(3y)10.26%
ROIC(5y)11.02%
CTAC.AS Yearly ROA, ROE, ROICCTAC.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • CTAC has a Profit Margin (2.86%) which is in line with its industry peers.
  • CTAC's Profit Margin has declined in the last couple of years.
  • The Operating Margin of CTAC (2.63%) is worse than 71.43% of its industry peers.
  • CTAC's Operating Margin has declined in the last couple of years.
  • CTAC has a Gross Margin of 35.24%. This is in the lower half of the industry: CTAC underperforms 68.57% of its industry peers.
  • CTAC's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.63%
PM (TTM) 2.86%
GM 35.24%
OM growth 3Y-12.38%
OM growth 5Y-6.66%
PM growth 3Y-10.68%
PM growth 5Y-3.79%
GM growth 3Y-5.01%
GM growth 5Y-4.72%
CTAC.AS Yearly Profit, Operating, Gross MarginsCTAC.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. CTAC.AS Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CTAC is creating some value.
  • CTAC has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, CTAC has more shares outstanding
  • Compared to 1 year ago, CTAC has an improved debt to assets ratio.
CTAC.AS Yearly Shares OutstandingCTAC.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M
CTAC.AS Yearly Total Debt VS Total AssetsCTAC.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • An Altman-Z score of 4.03 indicates that CTAC is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 4.03, CTAC belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
  • CTAC has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
  • With a decent Debt to Equity ratio value of 0.16, CTAC is doing good in the industry, outperforming 74.29% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z 4.03
ROIC/WACC1.44
WACC6.74%
CTAC.AS Yearly LT Debt VS Equity VS FCFCTAC.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M 30M

2.3 Liquidity

  • CTAC has a Current Ratio of 1.10. This is a normal value and indicates that CTAC is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.10, CTAC is doing worse than 64.29% of the companies in the same industry.
  • CTAC has a Quick Ratio of 1.10. This is a normal value and indicates that CTAC is financially healthy and should not expect problems in meeting its short term obligations.
  • CTAC's Quick ratio of 1.10 is on the low side compared to the rest of the industry. CTAC is outperformed by 60.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 1.1
CTAC.AS Yearly Current Assets VS Current LiabilitesCTAC.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. CTAC.AS Growth Analysis

3.1 Past

  • The earnings per share for CTAC have decreased by -7.93% in the last year.
  • Measured over the past 5 years, CTAC shows a small growth in Earnings Per Share. The EPS has been growing by 2.95% on average per year.
  • The Revenue has been growing slightly by 1.11% in the past year.
  • The Revenue has been growing slightly by 7.56% on average over the past years.
EPS 1Y (TTM)-7.93%
EPS 3Y-9.43%
EPS 5Y2.95%
EPS Q2Q%-18.74%
Revenue 1Y (TTM)1.11%
Revenue growth 3Y2.23%
Revenue growth 5Y7.56%
Sales Q2Q%0.78%

3.2 Future

  • The Earnings Per Share is expected to decrease by 0.00% on average over the next years.
  • CTAC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.04% yearly.
EPS Next Y16.07%
EPS Next 2Y7.74%
EPS Next 3Y0%
EPS Next 5YN/A
Revenue Next Year4.33%
Revenue Next 2Y4.24%
Revenue Next 3Y2.31%
Revenue Next 5Y7.04%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CTAC.AS Yearly Revenue VS EstimatesCTAC.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M
CTAC.AS Yearly EPS VS EstimatesCTAC.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.1 0.2 0.3

More info and screens

Find the best growth stocksShow best growing peers

6

4. CTAC.AS Valuation Analysis

4.1 Price/Earnings Ratio

  • CTAC is valuated reasonably with a Price/Earnings ratio of 11.68.
  • CTAC's Price/Earnings ratio is rather cheap when compared to the industry. CTAC is cheaper than 85.71% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.64. CTAC is valued rather cheaply when compared to this.
  • The Price/Forward Earnings ratio is 8.81, which indicates a very decent valuation of CTAC.
  • CTAC's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CTAC is cheaper than 80.00% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of CTAC to the average of the S&P500 Index (21.36), we can say CTAC is valued rather cheaply.
Industry RankSector Rank
PE 11.68
Fwd PE 8.81
CTAC.AS Price Earnings VS Forward Price EarningsCTAC.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CTAC is valued cheaper than 84.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.33
CTAC.AS Per share dataCTAC.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • CTAC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.73
PEG (5Y)3.96
EPS Next 2Y7.74%
EPS Next 3Y0%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. CTAC.AS Dividend Analysis

5.1 Amount

  • CTAC has a Yearly Dividend Yield of 3.77%.
  • Compared to an average industry Dividend Yield of 2.77, CTAC pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.80, CTAC pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.77%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2
CTAC.AS Yearly Dividends per shareCTAC.AS Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.02 0.04 0.06 0.08 0.1

5.3 Sustainability

  • 28.82% of the earnings are spent on dividend by CTAC. This is a low number and sustainable payout ratio.
DP28.82%
EPS Next 2Y7.74%
EPS Next 3Y0%
CTAC.AS Yearly Income VS Free CF VS DividendCTAC.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M 10M
CTAC.AS Dividend Payout.CTAC.AS Dividend Payout, showing the Payout Ratio.CTAC.AS Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CTAC.AS Fundamentals: All Metrics, Ratios and Statistics

CTAC NV

AMS:CTAC (4/30/2026, 7:00:00 PM)

2.92

+0.06 (+2.1%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Industry Strength14.86
Industry Growth42.67
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners2.89%
Inst Owner ChangeN/A
Ins Owners22.2%
Ins Owner ChangeN/A
Market Cap41.32M
Revenue(TTM)188.71M
Net Income(TTM)5.40M
Analysts80
Price Target2.87 (-1.71%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.77%
Yearly Dividend0.11
Dividend Growth(5Y)N/A
DP28.82%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-3.44%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-22.62%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.36%
Valuation
Industry RankSector Rank
PE 11.68
Fwd PE 8.81
P/S 0.22
P/FCF N/A
P/OCF 65.69
P/B 1.26
P/tB 5.79
EV/EBITDA 4.33
EPS(TTM)0.25
EY8.56%
EPS(NY)0.33
Fwd EY11.35%
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)0.04
OCFY1.52%
SpS13.34
BVpS2.33
TBVpS0.5
PEG (NY)0.73
PEG (5Y)3.96
Graham Number3.61688 (23.87%)
Profitability
Industry RankSector Rank
ROA 7.74%
ROE 16.41%
ROCE 12.62%
ROIC 9.71%
ROICexc 11%
ROICexgc 42.74%
OM 2.63%
PM (TTM) 2.86%
GM 35.24%
FCFM N/A
ROA(3y)3.98%
ROA(5y)4.84%
ROE(3y)8.98%
ROE(5y)11.99%
ROIC(3y)10.26%
ROIC(5y)11.02%
ROICexc(3y)12.83%
ROICexc(5y)13.89%
ROICexgc(3y)121.73%
ROICexgc(5y)145.43%
ROCE(3y)13.49%
ROCE(5y)14.56%
ROICexgc growth 3Y-18.29%
ROICexgc growth 5Y-22.64%
ROICexc growth 3Y-9.77%
ROICexc growth 5Y-4.88%
OM growth 3Y-12.38%
OM growth 5Y-6.66%
PM growth 3Y-10.68%
PM growth 5Y-3.79%
GM growth 3Y-5.01%
GM growth 5Y-4.72%
F-Score6
Asset Turnover2.71
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA 0.52
Cap/Depr 28.44%
Cap/Sales 0.81%
Interest Coverage 13.63
Cash Conversion 6.08%
Profit Quality N/A
Current Ratio 1.1
Quick Ratio 1.1
Altman-Z 4.03
F-Score6
WACC6.74%
ROIC/WACC1.44
Cap/Depr(3y)42.32%
Cap/Depr(5y)33.13%
Cap/Sales(3y)1.77%
Cap/Sales(5y)1.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7.93%
EPS 3Y-9.43%
EPS 5Y2.95%
EPS Q2Q%-18.74%
EPS Next Y16.07%
EPS Next 2Y7.74%
EPS Next 3Y0%
EPS Next 5YN/A
Revenue 1Y (TTM)1.11%
Revenue growth 3Y2.23%
Revenue growth 5Y7.56%
Sales Q2Q%0.78%
Revenue Next Year4.33%
Revenue Next 2Y4.24%
Revenue Next 3Y2.31%
Revenue Next 5Y7.04%
EBIT growth 1Y-10.74%
EBIT growth 3Y-10.42%
EBIT growth 5Y0.4%
EBIT Next Year118.18%
EBIT Next 3Y29.7%
EBIT Next 5YN/A
FCF growth 1Y-112.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-93.88%
OCF growth 3Y-52.08%
OCF growth 5Y-47.08%

CTAC NV / CTAC.AS Fundamental Analysis FAQ

What is the fundamental rating for CTAC stock?

ChartMill assigns a fundamental rating of 4 / 10 to CTAC.AS.


Can you provide the valuation status for CTAC NV?

ChartMill assigns a valuation rating of 6 / 10 to CTAC NV (CTAC.AS). This can be considered as Fairly Valued.


What is the profitability of CTAC stock?

CTAC NV (CTAC.AS) has a profitability rating of 4 / 10.


How financially healthy is CTAC NV?

The financial health rating of CTAC NV (CTAC.AS) is 4 / 10.


Can you provide the expected EPS growth for CTAC stock?

The Earnings per Share (EPS) of CTAC NV (CTAC.AS) is expected to grow by 16.07% in the next year.